London, United Kingdom, 27th July 2026, FinanceWire … Read More
Medical
InkWell Health Surpasses Halfway Mark in $2.2M Seed Round as Data-Driven Recovery Care Gains Investor Momentum
Troy,Michigan, United States, 24th July 2026, FinanceWire … Read More
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
WSW, NY, 23rd July 2026, FinanceWire … Read More
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
WSW, NY, 22nd July 2026, FinanceWire … Read More
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
WSW, NY, 21st July 2026, FinanceWire … Read More
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
WSW, NY, 16th July 2026, FinanceWire … Read More
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
WSW, NY, 16th July 2026, FinanceWire … Read More
After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?
WSW, NY, 15th July 2026, FinanceWire … Read More
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
WSW, NY, 14th July 2026, FinanceWire … Read More
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
WSW, NY, 9th July 2026, FinanceWire … Read More